BDX
Healthcare · Medical Instruments & Supplies
Performance
BDX (BDX) Stock Analysis 2026
Rule-based · Updated daily · Not financial advice
BDX (BDX) operates in the Medical Instruments & Supplies space within the Healthcare sector. With a market cap of $40.2B, it qualifies as a mid-cap company. Growth is moderate and the business remains profitable, offering a balanced risk/reward profile compared to high-multiple peers.
- Forward P/E (10.9×) is lower than trailing P/E (25.5×) — analysts expect earnings to improve
- Revenue growth of 5% YoY shows solid business momentum
- Dividend yield of 2.89% provides consistent income on top of price appreciation
- Low beta of 0.28 — less volatile than the market, suitable for conservative portfolios
- P/E of 25.5× is above average — valuation requires continued strong growth to justify
- High debt-to-equity of 71.60× increases financial risk, especially with elevated interest rates
- Current ratio below 1 (0.94×) — short-term liabilities exceed current assets
Verdict
Buy / Hold
More positives than negatives. Fundamentals support holding while monitoring key risks.
AI Insight
Powered by ClaudeAI-generated analysis for informational purposes only. Not financial advice.
Related Articles
Revenue & Results
Dividends
Current DY
2.89%
5Y Avg Annual
$2.8160
Last Payment
$1.0500
Ex-Date
06/09/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest06/09/2026 | 06/30/2026 | $1.0500 | 2.88% |
03/10/2026 | 03/31/2026 | $1.0500 | 2.88% |
12/08/2025 | 12/29/2025 | $0.8255 | 2.26% |
09/08/2025 | 09/29/2025 | $0.8176 | 2.24% |
06/09/2025 | 06/30/2025 | $0.8176 | 2.24% |
03/10/2025 | 03/31/2025 | $0.8176 | 2.24% |
12/09/2024 | 12/30/2024 | $0.8176 | 2.24% |
09/09/2024 | 09/30/2024 | $0.7469 | 2.05% |
Magic Number
Shares needed to self-fund your next purchase
$145.93
Price
$1.0500
Last div. (quarterly)
139
shares
Own 139 BDX shares ($20,284.27) and each quarterly dividend pays for 1 new share — the snowball runs on its own.
Investment target
$20,284.27
New shares / year
+4 shares
If You Had Invested…
Hypothetical return based on historical prices
* Dividend reinvestment calculated at ex-date price. For informational purposes only.
Earnings
Next Earnings
Aug 6, 2026
51
days
EPS (TTM)
$5.73
P/E (TTM)
25.5
Fwd P/E
10.9
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Key Statistics
Valuation
Trading
Dividends
Profitability
Balance Sheet
Fair Value Estimates
Current price: $145.93
Graham Number
√(22.5 × EPS × Book Value)
$106.26
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$48.52
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
6/10
67% score
Pays dividends
15Y hist.15+ years of dividend history
Dividend consistency (5Y+)
15 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
6.7%Return on equity — measures how efficiently capital is used
Positive profit margin
5.1%Net profit margin must be positive — company earns more than it spends
Revenue growth (annual)
+5.2%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
71.60×Low financial leverage reduces risk of distress
Current ratio above 1
0.94×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$402M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
2.89%Stock must distribute income to shareholders
Related Assets
Healthcare
About BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Location
Franklin Lakes, United States
Employees
60,000